(NP (NP (JJ Glucocorticoid-mediated) (NN inhibition)) (PP (IN of) (NP (NP (NN interleukin-2) (NN receptor) (NP-COOD (NP (NN alpha)) (CC and) (NP (NN -beta))) (NN subunit) (NN expression)) (PP (IN by) (NP (JJ human) (NN T) (NNS cells))))) (. .))
(S (S (NP-SBJ (-NONE- *)) (VP (TO To) (VP (VB determine) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NP (ADJP (NN glucocorticoid) (-LRB- -LRB-) (NN GC) (-RRB- -RRB-) (JJ -mediated)) (NN inhibition)) (PP (IN of) (NP (NN T) (NN cell) (NNS functions))))))))) (, ,) (NP-SBJ-8 (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NN dexamethasone)) (PRN (-LRB- -LRB-) (NP (NN DM)) (-RRB- -RRB-)))) (PP (IN on) (NP-COOD (NP (NN T) (NN cell) (NN proliferation)) (CC and) (NP (NP (NP (NN interleukin-2) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN IL-2R)) (-RRB- -RRB-))) (NN generation))))) (VP (VBD were) (VP (VBN studied) (NP (-NONE- *-8)))) (. .))
(S (NP-SBJ (NN Dexamethasone)) (VP (VBD inhibited) (NP (JJ IL-2-induced) (NN T) (NN cell) (NN proliferation)) (PP (IN by) (NP (CD 30) (NN %) (TO -) (CD 88) (NN %))) (, ,) (PP (JJ relative) (TO to) (NP (NP (PRP$ its) (NN concentration)) (PP (IN within) (NP (DT the) (NNS cultures)))))) (. .))
(S (NP-SBJ-9 (NP (DT The) (NN effect)) (PP (IN of) (NP (NN DM))) (PP (IN on) (NP (NP (NN expression)) (PP (IN of) (NP (NP-COOD (NP (NP (NN IL-2R) (NN alpha)) (PRN (-LRB- -LRB-) (NP-COOD (NP (NN Tac)) (, ,) (NP (NN p55)) (, ,) (NP (NN CD25))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (-NONE- *?*)) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN p75)) (-RRB- -RRB-)))) (NNS genes))) (PP (IN in) (NP (VBN activated) (NN T) (NNS cells)))))) (VP (VBD was) (VP (VBN examined) (NP (-NONE- *-9)) (ADVP-TMP (RB next)))) (. .))
(S (PP (IN In) (NP (NP (NN T) (NNS cells)) (VP (VBN stimulated) (NP (-NONE- *)) (PP (IN with) (NP-COOD (NP (NP (VBN purified) (NN phytohemagglutinin)) (PRN (-LRB- -LRB-) (NP (NN PHA-p)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 4) (NN beta-phorbol) (NN 12-myristate) (NN 13-acetate)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-)))))))) (NP-SBJ-10 (NP (NN addition)) (PP (IN of) (NP (NN DM))) (PP (TO to) (NP (DT the) (NNS cultures)))) (VP (VBD resulted) (PP (IN in) (NP-COOD (NP (NP (DT a) (CD 60) (NN %) (NN reduction)) (PP (IN in) (NP (NN IL-2R) (NN alpha)))) (CC and) (NP (NP (DT a) (CD 30) (NN %) (NN reduction)) (PP (IN in) (NP (NN IL-2R) (NN beta) (NN membrane) (NN expression)))))) (S (NP-SBJ-11 (-NONE- *-10)) (VP (VBN compared) (NP (-NONE- *-11)) (PP (TO to) (NP (NP (NN T) (NNS cells)) (VP (VBN cultured) (NP (-NONE- *)) (PP (IN in) (DT the) (NN absence) (IN of) (NP (NN DM))) (PRN (-LRB- -LRB-) (S (NP-SBJ (NN p)) (NP-PRD (QP (JJR &lt;) (CD 0.01)))) (-RRB- -RRB-)))))))) (. .))
(S (NP-SBJ (NP (NN Inhibition)) (PP (IN of) (NP (NN membrane) (NP-COOD (NP (NN IL-2R) (NN alpha)) (CC and) (NP (NN IL-2R) (NN beta))) (NN expression))) (PP (IN by) (NP (ADJP (CD 10-LRB--6-RRB-) (NN M)) (NN DM)))) (VP (VBD was) (ADJP-PRD (RB partially) (JJ reversible) (PP (IN by) (NP (NP (JJ recombinant) (JJ human) (NN IL-2)) (PRN (-LRB- -LRB-) (NP (NN rhIL-2)) (-RRB- -RRB-)))))) (. .))
(S (PP (IN By) (NP (JJ Northern) (NN blot) (NN analysis))) (, ,) (NP-SBJ (NN DM)) (VP (VBD caused) (NP (NP (DT a) (JJ comparable) (NN decrease)) (PP (PP-COOD (PP (IN in) (NP (NN IL-2R) (NN alpha) (NP (-NONE- *RNR*-12)))) (CC and) (PP (IN in) (NP (NN IL-2R) (NN beta) (NP (-NONE- *RNR*-12))))) (NP-12 (NN mRNA) (NNS levels)))) (PP (TO to) (NP (NP (NN membrane) (NN receptor) (NN expression)) (PP (IN in) (NP (JJ mitogen-stimulated) (NN T) (NNS cells)))))) (. .))
(S (PP (IN By) (NP (ADJP (FW in) (FW vitro)) (NN transcription) (NNS assays))) (, ,) (NP-SBJ (NN DM)) (VP (VBD regulated) (NP (NP (NN IL-2R) (NN alpha) (NN gene) (NN expression)) (PP (IN at) (NP (DT a) (JJ transcriptional) (NN level)))) (SBAR (IN while) (S (NP-SBJ-13 (NP (NN transcription)) (PP (IN of) (NP (NN IL-2R) (NN beta) (NN gene)))) (VP (VBD was) (VP (VBN unaffected) (NP (-NONE- *-13)) (PP (IN by) (NP-LGS (NN DM)))))))) (. .))
(S (NP-SBJ-14 (NP (DT The) (NN mechanism)) (PP (IN of) (NP (NP (NN action)) (PP (IN of) (NP (NN DM))) (PP (IN on) (NP (NN IL-2R) (NN alpha) (NN transcription)))))) (VP (VBD was) (VP (VBN examined) (NP (-NONE- *-14)) (PP (IN by) (S (NP-SBJ (-NONE- *)) (VP (VBG determining) (NP (NP (DT the) (NN mRNA) (NNS levels)) (PP (IN of) (NP (NP (DT the) (NN p50) (NN subunit)) (PP (IN of) (NP (NP (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN transcription) (NN factor)) (SBAR (WHNP-15 (WDT that)) (S (NP-SBJ (-NONE- *T*-15)) (VP (VBZ stimulates) (NP (NN IL-2R) (NN alpha) (NN gene) (NN expression)))))))))))))))) (. .))
(S (NP-SBJ (DT The) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ-16 (ADJP (CD 10-LRB--6-RRB-) (NN M)) (NN DM)) (VP (VBD increased) (NP (NN T) (NN cell) (NN p50) (NN NF-kappa) (NN B) (NN mRNA) (NNS levels)) (PP (IN by) (NP (JJ four-fold))) (S (NP-SBJ-17 (-NONE- *-16)) (VP (VBN compared) (NP (-NONE- *-17)) (PP (TO to) (NP (NP (DT the) (NNS levels)) (VP (VBN obtained) (NP (-NONE- *)) (PP (IN in) (DT the) (NN absence) (IN of) (NP (NN DM)))))))))))) (. .))
(S (ADVP (RB Further)) (, ,) (NP-SBJ (NP (DT the) (NN level)) (PP (IN of) (NP (NP (JJ nuclear) (NNS proteins)) (ADJP (JJ capable) (PP (IN of) (S (NP-SBJ (-NONE- *)) (VP (VBG binding) (PP (TO to) (NP (DT the) (NN NF-kappa) (NN B) (NNS sites))) (PP (IN in) (NP (VBN activated) (NN T) (NNS cells)))))))))) (VP (VBD increased) (PP (IN in) (NN response) (TO to) (NP (NN DM)))) (. .))
(S (PP (IN In) (NP (NN sum))) (, ,) (NP-SBJ (NN DM)) (VP (VBZ regulates) (NP (NP (NN T) (NN cell) (NN membrane) (NN expression)) (PP (IN of) (NP (NN IL-2R)))) (PP (IN by) (NP (QP (JJR more) (IN than) (CD one)) (JJ molecular) (NN mechanism)))) (. .))
